{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:44:25Z","timestamp":1793321065649,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1038\/s41593-020-0599-5","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T17:03:11Z","timestamp":1582909391000},"page":"311-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":441,"title":["The multiplex model of the genetics of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"23","author":[{"given":"Rebecca","family":"Sims","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-0259","authenticated-orcid":false,"given":"Julie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"599_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 349, 704\u2013706 (1991).","journal-title":"Nature"},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 375, 754\u2013760 (1995).","journal-title":"Nature"},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev, E. I. et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature 376, 775\u2013778 (1995).","journal-title":"Nature"},{"key":"599_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","volume":"15","author":"R Ricciarelli","year":"2017","unstructured":"Ricciarelli, R. & Fedele, E. The amyloid cascade hypothesis in Alzheimer\u2019s disease: it\u2019s time to change our mind. Curr. Neuropharmacol. 15, 926\u2013935 (2017).","journal-title":"Curr. Neuropharmacol."},{"key":"599_CR6","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody, R. S., Farlow, M. & Aisen, P. S., Alzheimer\u2019s Disease Cooperative Study Data Analysis and Publication Committee. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer\u2019s disease. N. Engl. J. Med. 370, 1460 (2014).","journal-title":"N. Engl. J. Med."},{"key":"599_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig, L. S. et al. Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease. N. Engl. J. Med. 378, 321\u2013330 (2018).","journal-title":"N. Engl. J. Med."},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1756285611404470","volume":"4","author":"D Galimberti","year":"2011","unstructured":"Galimberti, D. & Scarpini, E. Disease-modifying treatments for Alzheimer\u2019s disease. Ther. Adv. Neurol. Disord. 4, 203\u2013216 (2011).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756285612461679","volume":"6","author":"KG Yiannopoulou","year":"2013","unstructured":"Yiannopoulou, K. G. & Papageorgiou, S. G. Current and future treatments for Alzheimer\u2019s disease. Ther. Adv. Neurol. Disord. 6, 19\u201333 (2013).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"599_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","volume":"19","author":"W Jagust","year":"2018","unstructured":"Jagust, W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat. Rev. Neurosci. 19, 687\u2013700 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"599_CR11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1212\/WNL.0000000000001774","volume":"85","author":"KB Rajan","year":"2015","unstructured":"Rajan, K. B., Wilson, R. S., Weuve, J., Barnes, L. L. & Evans, D. A. Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia. Neurology 85, 898\u2013904 (2015).","journal-title":"Neurology"},{"key":"599_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neurobiolaging.2013.10.085","volume":"35","author":"WI Rosenblum","year":"2014","unstructured":"Rosenblum, W. I. Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult. Neurobiol. Aging 35, 969\u2013974 (2014).","journal-title":"Neurobiol. Aging"},{"key":"599_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz, M. et al. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63, 168\u2013174 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneurol.2011.221","volume":"69","author":"TS Wingo","year":"2012","unstructured":"Wingo, T. S., Lah, J. J., Levey, A. I. & Cutler, D. J. Autosomal recessive causes likely in early-onset Alzheimer disease. Arch. Neurol. 69, 59\u201364 (2012).","journal-title":"Arch. Neurol."},{"key":"599_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/0140-6736(93)91709-U","volume":"342","author":"AM Saunders","year":"1993","unstructured":"Saunders, A. M. et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer\u2019s disease and in other amyloid-forming diseases. Lancet 342, 710\u2013711 (1993).","journal-title":"Lancet"},{"key":"599_CR16","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 1977\u20131981 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"599_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder, E. H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180\u2013184 (1994).","journal-title":"Nat. Genet."},{"key":"599_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/MOL.0000000000000383","volume":"28","author":"F Liao","year":"2017","unstructured":"Liao, F., Yoon, H. & Kim, J. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer\u2019s disease. Curr. Opin. Lipidol. 28, 60\u201367 (2017).","journal-title":"Curr. Opin. Lipidol."},{"key":"599_CR19","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane, R. et al. ApoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J. Clin. Invest. 118, 4002\u20134013 (2008).","journal-title":"J. Clin. Invest."},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese, P. B., Castellano, J. M. & Holtzman, D. M. Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol. 10, 241\u2013252 (2011).","journal-title":"Lancet Neurol."},{"key":"599_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1088\u20131093 (2009).","journal-title":"Nat. Genet."},{"key":"599_CR22","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1094\u20131099 (2009).","journal-title":"Nat. Genet."},{"key":"599_CR23","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri, S. et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. J. Am. Med. Assoc. 303, 1832\u20131840 (2010).","journal-title":"J. Am. Med. Assoc."},{"key":"599_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj, A. C. et al. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat. Genet. 43, 436\u2013441 (2011).","journal-title":"Nat. Genet."},{"key":"599_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth, P. et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat. Genet. 43, 429\u2013435 (2011).","journal-title":"Nat. Genet."},{"key":"599_CR26","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat. Genet. 45, 1452\u20131458 (2013).","journal-title":"Nat. Genet."},{"key":"599_CR27","doi-asserted-by":"publisher","first-page":"e1002258","DOI":"10.1371\/journal.pmed.1002258","volume":"14","author":"RS Desikan","year":"2017","unstructured":"Desikan, R. S. et al. Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score. PLoS Med. 14, e1002258 (2017).","journal-title":"PLoS Med."},{"key":"599_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-018-0282-4","volume":"13","author":"ECB Johnson","year":"2018","unstructured":"Johnson, E. C. B. et al. Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol. Neurodegener. 13, 52 (2018).","journal-title":"Mol. Neurodegener."},{"key":"599_CR29","doi-asserted-by":"publisher","first-page":"eaap8757","DOI":"10.1126\/science.aap8757","volume":"360","author":"V Anttila","year":"2018","unstructured":"Anttila, V. et al. Analysis of shared heritability in common disorders of the brain. Science 360, eaap8757 (2018).","journal-title":"Science"},{"key":"599_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.2","volume":"4","author":"A Ruiz","year":"2014","unstructured":"Ruiz, A. et al. Follow-up of loci from the International Genomics of Alzheimer\u2019s Disease Project identifies TRIP4 as a novel susceptibility gene. Transl. Psychiatry 4, e358 (2014).","journal-title":"Transl. Psychiatry"},{"key":"599_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"599_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jalz.2016.12.012","volume":"13","author":"GR Jun","year":"2017","unstructured":"Jun, G. R. et al. Transethnic genome-wide scan identifies novel Alzheimer\u2019s disease loci. Alzheimers Dement. 13, 727\u2013738 (2017).","journal-title":"Alzheimers Dement."},{"key":"599_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"599_CR34","doi-asserted-by":"publisher","unstructured":"de Rojas, I., et al. Common variants in Alzheimer\u2019s disease: novel association of six genetic variants with AD and risk stratification by polygenic risk scores. Preprint at medRxiv https:\/\/doi.org\/10.1101\/19012021 (2019).","DOI":"10.1101\/19012021"},{"key":"599_CR35","doi-asserted-by":"publisher","first-page":"e94661","DOI":"10.1371\/journal.pone.0094661","volume":"9","author":"V Escott-Price","year":"2014","unstructured":"Escott-Price, V. et al. Gene-wide analysis detects two new susceptibility genes for Alzheimer\u2019s disease. PLoS One 9, e94661 (2014).","journal-title":"PLoS One"},{"key":"599_CR36","doi-asserted-by":"publisher","first-page":"e0218111","DOI":"10.1371\/journal.pone.0218111","volume":"14","author":"E Baker","year":"2019","unstructured":"Baker, E. et al. Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer\u2019s disease. PLoS One 14, e0218111 (2019).","journal-title":"PLoS One"},{"key":"599_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0150-6","volume":"8","author":"RE Marioni","year":"2018","unstructured":"Marioni, R. E. et al. GWAS on family history of Alzheimer\u2019s disease. Transl. Psychiatry 8, 99 (2018).","journal-title":"Transl. Psychiatry"},{"key":"599_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ng.3766","volume":"49","author":"JZ Liu","year":"2017","unstructured":"Liu, J. Z., Erlich, Y. & Pickrell, J. K. Case-control association mapping by proxy using family history of disease. Nat. Genet. 49, 325\u2013331 (2017).","journal-title":"Nat. Genet."},{"key":"599_CR39","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/gepi.20579","volume":"35","author":"HC So","year":"2011","unstructured":"So, H. C., Gui, A. H., Cherny, S. S. & Sham, P. C. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet. Epidemiol. 35, 310\u2013317 (2011).","journal-title":"Genet. Epidemiol."},{"key":"599_CR40","doi-asserted-by":"publisher","first-page":"e79771","DOI":"10.1371\/journal.pone.0079771","volume":"8","author":"PG Ridge","year":"2013","unstructured":"Ridge, P. G., Mukherjee, S., Crane, P. K. & Kauwe, J. S. Alzheimer\u2019s Disease Genetics Consortium. Alzheimer\u2019s disease: analyzing the missing heritability. PLoS One 8, e79771 (2013).","journal-title":"PLoS One"},{"key":"599_CR41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ebiom.2018.01.023","volume":"28","author":"W Meng","year":"2018","unstructured":"Meng, W. et al. A genome-wide association study finds genetic associations with broadly-defined headache in UK Biobank (N=223,773). EBioMedicine 28, 180\u2013186 (2018).","journal-title":"EBioMedicine"},{"key":"599_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"B Kunkle","year":"2019","unstructured":"Kunkle, B. et al. Meta-analysis of genetic association with diagnosed Alzheimer\u2019s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"599_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro, R. et al. TREM2 variants in Alzheimer\u2019s disease. N. Engl. J. Med. 368, 117\u2013127 (2013).","journal-title":"N. Engl. J. Med."},{"key":"599_CR44","doi-asserted-by":"publisher","unstructured":"Bis, J.C. et al. Whole exome sequencing study identifies novel rare and common Alzheimer\u2019s-associated variants involved in immune response and transcriptional regulation. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-018-0112-7 (2018).","DOI":"10.1038\/s41380-018-0112-7"},{"key":"599_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 (2013).","journal-title":"N. Engl. J. Med."},{"key":"599_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson, T. et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488, 96\u201399 (2012).","journal-title":"Nature"},{"key":"599_CR47","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jamaneurol.2017.1518","volume":"74","author":"BW Kunkle","year":"2017","unstructured":"Kunkle, B. W. et al. Early-onset Alzheimer disease and candidate risk genes involved in endolysosomal transport. JAMA Neurol. 74, 1113\u20131122 (2017).","journal-title":"JAMA Neurol."},{"key":"599_CR48","doi-asserted-by":"publisher","first-page":"220.e1","DOI":"10.1016\/j.neurobiolaging.2017.07.001","volume":"59","author":"C Bellenguez","year":"2017","unstructured":"Bellenguez, C. et al. Contribution to Alzheimer\u2019s disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls. Neurobiol. Aging 59, 220.e1\u2013220.e9 (2017).","journal-title":"Neurobiol. Aging"},{"key":"599_CR49","doi-asserted-by":"publisher","first-page":"1605.e13","DOI":"10.1016\/j.neurobiolaging.2014.12.007","volume":"36","author":"E Louwersheimer","year":"2015","unstructured":"Louwersheimer, E. et al. Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer\u2019s disease. Neurobiol. Aging 36, 1605.e13\u20131605.e20 (2015).","journal-title":"Neurobiol. Aging"},{"key":"599_CR50","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"S Steinberg","year":"2015","unstructured":"Steinberg, S. et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer\u2019s disease. Nat. Genet. 47, 445\u2013447 (2015).","journal-title":"Nat. Genet."},{"key":"599_CR51","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature12825","volume":"505","author":"C Cruchaga","year":"2014","unstructured":"Cruchaga, C. et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer\u2019s disease. Nature 505, 550\u2013554 (2014).","journal-title":"Nature"},{"key":"599_CR52","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jalz.2014.06.010","volume":"10","author":"MW Logue","year":"2014","unstructured":"Logue, M. W. et al. Two rare AKAP9 variants are associated with Alzheimer\u2019s disease in African Americans. Alzheimers Dement. 10, 609\u2013618.e11 (2014).","journal-title":"Alzheimers Dement."},{"key":"599_CR53","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/nm.3736","volume":"20","author":"MK Wetzel-Smith","year":"2014","unstructured":"Wetzel-Smith, M. K. et al. A rare mutation in UNC5C predisposes to late-onset Alzheimer\u2019s disease and increases neuronal cell death. Nat. Med. 20, 1452\u20131457 (2014).","journal-title":"Nat. Med."},{"key":"599_CR54","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat. Genet. 49, 1373\u20131384 (2017).","journal-title":"Nat. Genet."},{"key":"599_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-019-0469-0","volume":"11","author":"L Magno","year":"2019","unstructured":"Magno, L. et al. Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimers Res. Ther. 11, 16 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"599_CR56","doi-asserted-by":"publisher","first-page":"188.e3","DOI":"10.1016\/j.neurobiolaging.2018.08.001","volume":"72","author":"ES Gusareva","year":"2018","unstructured":"Gusareva, E. S. et al. Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer\u2019s disease. Neurobiol. Aging 72, 188.e3\u2013188.e12 (2018).","journal-title":"Neurobiol. Aging"},{"key":"599_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0486-1","volume":"9","author":"PG Ridge","year":"2017","unstructured":"Ridge, P. G. et al. Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer\u2019s disease resilience. Genome Med. 9, 100 (2017).","journal-title":"Genome Med."},{"key":"599_CR58","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1176\/appi.ajp.162.11.2022","volume":"162","author":"SA Ropacki","year":"2005","unstructured":"Ropacki, S. A. & Jeste, D. V. Epidemiology of and risk factors for psychosis of Alzheimer\u2019s disease: a review of 55 studies published from 1990 to 2003. Am. J. Psychiatry 162, 2022\u20132030 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"599_CR59","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00019442-200506000-00005","volume":"13","author":"IS Shin","year":"2005","unstructured":"Shin, I. S., Carter, M., Masterman, D., Fairbanks, L. & Cummings, J. L. Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am. J. Geriatr. Psychiatry 13, 469\u2013474 (2005).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"599_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1017\/S1041610209991001","volume":"22","author":"PA Wilkosz","year":"2010","unstructured":"Wilkosz, P. A. et al. Trajectories of cognitive decline in Alzheimer\u2019s disease. Int. Psychogeriatr. 22, 281\u2013290 (2010).","journal-title":"Int. Psychogeriatr."},{"key":"599_CR61","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/jnnp.2008.158964","volume":"80","author":"OL Lopez","year":"2009","unstructured":"Lopez, O. L. et al. Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. J. Neurol. Neurosurg. Psychiatry 80, 600\u2013607 (2009).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"599_CR62","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/mp.2011.125","volume":"17","author":"P Hollingworth","year":"2012","unstructured":"Hollingworth, P. et al. Genome-wide association study of Alzheimer\u2019s disease with psychotic symptoms. Mol. Psychiatry 17, 1316\u20131327 (2012).","journal-title":"Mol. Psychiatry"},{"key":"599_CR63","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3233\/JAD-170834","volume":"62","author":"JL Del-Aguila","year":"2018","unstructured":"Del-Aguila, J. L. et al. Assessment of the genetic architecture of Alzheimer\u2019s disease risk in rate of memory decline. J. Alzheimers Dis. 62, 745\u2013756 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"599_CR64","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1086\/429096","volume":"76","author":"LA Criswell","year":"2005","unstructured":"Criswell, L. A. et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76, 561\u2013571 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"599_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton, W. W., Rose, N. R., Kalaydjian, A., Pedersen, M. G. & Mortensen, P. B. Epidemiology of autoimmune diseases in Denmark. J. Autoimmun. 29, 1\u20139 (2007).","journal-title":"J. Autoimmun."},{"key":"599_CR66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrg3461","volume":"14","author":"N Solovieff","year":"2013","unstructured":"Solovieff, N., Cotsapas, C., Lee, P. H., Purcell, S. M. & Smoller, J. W. Pleiotropy in complex traits: challenges and strategies. Nat. Rev. Genet. 14, 483\u2013495 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"599_CR67","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ajhg.2011.10.004","volume":"89","author":"S Sivakumaran","year":"2011","unstructured":"Sivakumaran, S. et al. Abundant pleiotropy in human complex diseases and traits. Am. J. Hum. Genet. 89, 607\u2013618 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"599_CR68","first-page":"1268","volume":"70","author":"V Moskvina","year":"2013","unstructured":"Moskvina, V. et al. Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk. JAMA Neurol. 70, 1268\u20131276 (2013).","journal-title":"JAMA Neurol."},{"key":"599_CR69","doi-asserted-by":"publisher","first-page":"214.e7","DOI":"10.1016\/j.neurobiolaging.2015.10.028","volume":"38","author":"R Guerreiro","year":"2016","unstructured":"Guerreiro, R. et al. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson\u2019s and Alzheimer\u2019s diseases. Neurobiol. Aging 38, 214.e7\u2013214.e10 (2016).","journal-title":"Neurobiol. Aging"},{"key":"599_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nbd.2016.06.004","volume":"94","author":"JT Geiger","year":"2016","unstructured":"Geiger, J. T. et al. Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiol. Dis. 94, 55\u201362 (2016).","journal-title":"Neurobiol. Dis."},{"key":"599_CR71","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.neurobiolaging.2013.10.084","volume":"35","author":"G Liu","year":"2014","unstructured":"Liu, G. et al. Cardiovascular disease contributes to Alzheimer\u2019s disease: evidence from large-scale genome-wide association studies. Neurobiol. Aging 35, 786\u2013792 (2014).","journal-title":"Neurobiol. Aging"},{"key":"599_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ajhg.2009.05.011","volume":"85","author":"P Holmans","year":"2009","unstructured":"Holmans, P. et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet. 85, 13\u201324 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"599_CR73","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1093\/bioinformatics\/bts191","volume":"28","author":"PH Lee","year":"2012","unstructured":"Lee, P. H., O\u2019Dushlaine, C., Thomas, B. & Purcell, S. M. INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 28, 1797\u20131799 (2012).","journal-title":"Bioinformatics"},{"key":"599_CR74","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLOS Comput. Biol. 11, e1004219 (2015).","journal-title":"PLOS Comput. Biol."},{"key":"599_CR75","unstructured":"International Genomics of Alzheimer\u2019s Disease Consortium (IGAP). Convergent genetic and expression data implicate immunity in Alzheimer\u2019s disease. Alzheimers Dement. 11, 658\u2013671 (2015)."},{"key":"599_CR76","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/omi.2016.0063","volume":"20","author":"CH Yu","year":"2016","unstructured":"Yu, C. H., Pal, L. R. & Moult, J. Consensus genome-wide expression quantitative trait loci and their relationship with human complex trait disease. OMICS 20, 400\u2013414 (2016).","journal-title":"OMICS"},{"key":"599_CR77","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245\u2013252 (2016).","journal-title":"Nat. Genet."},{"key":"599_CR78","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/ng.3367","volume":"47","author":"ER Gamazon","year":"2015","unstructured":"Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091\u20131098 (2015).","journal-title":"Nat. Genet."},{"key":"599_CR79","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41588-018-0238-1","volume":"50","author":"T Raj","year":"2018","unstructured":"Raj, T. et al. Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer\u2019s disease susceptibility. Nat. Genet. 50, 1584\u20131592 (2018).","journal-title":"Nat. Genet."},{"key":"599_CR80","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/nn.3801","volume":"17","author":"A Ramasamy","year":"2014","unstructured":"Ramasamy, A. et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 17, 1418\u20131428 (2014).","journal-title":"Nat. Neurosci."},{"key":"599_CR81","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/nn.4156","volume":"18","author":"S Akbarian","year":"2015","unstructured":"Akbarian, S. et al. The PsychENCODE project. Nat. Neurosci. 18, 1707\u20131712 (2015).","journal-title":"Nat. Neurosci."},{"key":"599_CR82","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/nn.4399","volume":"19","author":"M Fromer","year":"2016","unstructured":"Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. 19, 1442\u20131453 (2016).","journal-title":"Nat. Neurosci."},{"key":"599_CR83","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1126\/science.1249547","volume":"344","author":"T Raj","year":"2014","unstructured":"Raj, T. et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 344, 519\u2013523 (2014).","journal-title":"Science"},{"key":"599_CR84","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnins.2016.00016","volume":"10","author":"NG Skene","year":"2016","unstructured":"Skene, N. G. & Grant, S. G. Identification of vulnerable cell types in major brain disorders using single cell transcriptomes and expression weighted cell type enrichment. Front. Neurosci. 10, 16 (2016).","journal-title":"Front. Neurosci."},{"key":"599_CR85","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41588-018-0129-5","volume":"50","author":"NG Skene","year":"2018","unstructured":"Skene, N. G. et al. Genetic identification of brain cell types underlying schizophrenia. Nat. Genet. 50, 825\u2013833 (2018).","journal-title":"Nat. Genet."},{"key":"599_CR86","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"599_CR87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond, T. R. et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253\u2013271.e6 (2019).","journal-title":"Immunity"},{"key":"599_CR88","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuron.2018.12.006","volume":"101","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing. Neuron 101, 207\u2013223.e10 (2019).","journal-title":"Neuron"},{"key":"599_CR89","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature14590","volume":"523","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro, J. D. et al. Single-cell chromatin accessibility reveals principles of regulatory variation. Nature 523, 486\u2013490 (2015).","journal-title":"Nature"},{"key":"599_CR90","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1126\/science.aab1601","volume":"348","author":"DA Cusanovich","year":"2015","unstructured":"Cusanovich, D. A. et al. Multiplex single cell profiling of chromatin accessibility by combinatorial cellular indexing. Science 348, 910\u2013914 (2015).","journal-title":"Science"},{"key":"599_CR91","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.celrep.2015.02.001","volume":"10","author":"M Farlik","year":"2015","unstructured":"Farlik, M. et al. Single-cell DNA methylome sequencing and bioinformatic inference of epigenomic cell-state dynamics. Cell Rep. 10, 1386\u20131397 (2015).","journal-title":"Cell Rep."},{"key":"599_CR92","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nbt.3973","volume":"35","author":"VM Peterson","year":"2017","unstructured":"Peterson, V. M. et al. Multiplexed quantification of proteins and transcripts in single cells. Nat. Biotechnol. 35, 936\u2013939 (2017).","journal-title":"Nat. Biotechnol."},{"key":"599_CR93","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"599_CR94","doi-asserted-by":"publisher","unstructured":"Olah, M. et al. A single cell-based atlas of human microglial states reveals associations with neurological disorders and histopathological features of the aging brain. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/343780 (2018).","DOI":"10.1101\/343780"},{"key":"599_CR95","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","volume":"21","author":"S Mostafavi","year":"2018","unstructured":"Mostafavi, S. et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat. Neurosci. 21, 811\u2013819 (2018).","journal-title":"Nat. Neurosci."},{"key":"599_CR96","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell 153, 707\u2013720 (2013).","journal-title":"Cell"},{"key":"599_CR97","doi-asserted-by":"publisher","first-page":"fcz022","DOI":"10.1093\/braincomms\/fcz022","volume":"1","author":"DA Salih","year":"2019","unstructured":"Salih, D.A. et al. Genetic variability in response to amyloid beta deposition influences Alzheimer\u2019s risk. Brain Commun. 1, fcz022 (2019).","journal-title":"Brain Commun."},{"key":"599_CR98","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature14252","volume":"518","author":"E Gjoneska","year":"2015","unstructured":"Gjoneska, E. et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease. Nature 518, 365\u2013369 (2015).","journal-title":"Nature"},{"key":"599_CR99","doi-asserted-by":"publisher","first-page":"e1006933","DOI":"10.1371\/journal.pgen.1006933","volume":"13","author":"Q Lu","year":"2017","unstructured":"Lu, Q. et al. Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer\u2019s disease. PLoS Genet. 13, e1006933 (2017).","journal-title":"PLoS Genet."},{"key":"599_CR100","doi-asserted-by":"publisher","unstructured":"Novikova, G. et al. Integration of Alzheimer\u2019s disease genetics and myeloid cell genomics identifies novel causal variants, regulatory elements, genes and pathways. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/694281 (2019).","DOI":"10.1101\/694281"},{"key":"599_CR101","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/JAD-190568","volume":"72","author":"A Amlie-Wolf","year":"2019","unstructured":"Amlie-Wolf, A. et al. Inferring the molecular mechanisms of noncoding Alzheimer\u2019s disease-associated genetic variants. J. Alzheimers Dis. 72, 301\u2013318 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"599_CR102","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.3404","volume":"47","author":"HK Finucane","year":"2015","unstructured":"Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228\u20131235 (2015).","journal-title":"Nat. Genet."},{"key":"599_CR103","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/nn.4587","volume":"20","author":"KL Huang","year":"2017","unstructured":"Huang, K. L. et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer\u2019s disease. Nat. Neurosci. 20, 1052\u20131061 (2017).","journal-title":"Nat. Neurosci."},{"key":"599_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0523-8","volume":"10","author":"KE Tansey","year":"2018","unstructured":"Tansey, K. E., Cameron, D. & Hill, M. J. Genetic risk for Alzheimer\u2019s disease is concentrated in specific macrophage and microglial transcriptional networks. Genome Med. 10, 14 (2018).","journal-title":"Genome Med."},{"key":"599_CR105","doi-asserted-by":"publisher","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).","journal-title":"Science"},{"key":"599_CR106","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin, M. et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 10, 633\u2013644 (2015).","journal-title":"Cell Rep."},{"key":"599_CR107","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2019.04.014","volume":"177","author":"X Liu","year":"2019","unstructured":"Liu, X., Li, Y. I. & Pritchard, J. K. Trans effects on gene expression can drive omnigenic inheritance. Cell 177, 1022\u20131034.e6 (2019).","journal-title":"Cell"},{"key":"599_CR108","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41588-018-0046-7","volume":"50","author":"K Alasoo","year":"2018","unstructured":"Alasoo, K. et al. Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response. Nat. Genet. 50, 424\u2013431 (2018).","journal-title":"Nat. Genet."},{"key":"599_CR109","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.aab1785","volume":"350","author":"MA Lodato","year":"2015","unstructured":"Lodato, M. A. et al. Somatic mutation in single human neurons tracks developmental and transcriptional history. Science 350, 94\u201398 (2015).","journal-title":"Science"},{"key":"599_CR110","doi-asserted-by":"publisher","first-page":"eaal1641","DOI":"10.1126\/science.aal1641","volume":"356","author":"MJ McConnell","year":"2017","unstructured":"McConnell, M. J. et al. Intersection of diverse neuronal genomes and neuropsychiatric disease: the brain somatic mosaicism network. Science 356, eaal1641 (2017).","journal-title":"Science"},{"key":"599_CR111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2353\/ajpath.2010.090955","volume":"177","author":"T Arendt","year":"2010","unstructured":"Arendt, T., Br\u00fcckner, M. K., Mosch, B. & L\u00f6sche, A. Selective cell death of hyperploid neurons in Alzheimer\u2019s disease. Am. J. Pathol. 177, 15\u201320 (2010).","journal-title":"Am. J. Pathol."},{"key":"599_CR112","doi-asserted-by":"publisher","first-page":"e05116","DOI":"10.7554\/eLife.05116","volume":"4","author":"DM Bushman","year":"2015","unstructured":"Bushman, D. M. et al. Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer\u2019s disease brains. eLife 4, e05116 (2015).","journal-title":"eLife"},{"key":"599_CR113","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-018-0718-6","volume":"563","author":"MH Lee","year":"2018","unstructured":"Lee, M. H. et al. Somatic APP gene recombination in Alzheimer\u2019s disease and normal neurons. Nature 563, 639\u2013645 (2018).","journal-title":"Nature"},{"key":"599_CR114","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/hmg\/dds491","volume":"22","author":"SH Lee","year":"2013","unstructured":"Lee, S. H. et al. Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer\u2019s disease, multiple sclerosis and endometriosis. Hum. Mol. Genet. 22, 832\u2013841 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"599_CR115","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1093\/brain\/awv268","volume":"138","author":"V Escott-Price","year":"2015","unstructured":"Escott-Price, V. et al. Common polygenic variation enhances risk prediction for Alzheimer\u2019s disease. Brain 138, 3673\u20133684 (2015).","journal-title":"Brain"},{"key":"599_CR116","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1474-4422(17)30202-8","volume":"16","author":"V Escott-Price","year":"2017","unstructured":"Escott-Price, V. & Jones, L. Genomic profiling and diagnostic biomarkers in Alzheimer\u2019s disease. Lancet Neurol. 16, 582\u2013583 (2017).","journal-title":"Lancet Neurol."},{"key":"599_CR117","doi-asserted-by":"publisher","first-page":"214.e7","DOI":"10.1016\/j.neurobiolaging.2016.07.018","volume":"49","author":"V Escott-Price","year":"2017","unstructured":"Escott-Price, V., Shoai, M., Pither, R., Williams, J. & Hardy, J. Polygenic score prediction captures nearly all common genetic risk for Alzheimer\u2019s disease. Neurobiol. Aging 49, 214.e7\u2013214.e11 (2017).","journal-title":"Neurobiol. Aging"},{"key":"599_CR118","doi-asserted-by":"publisher","first-page":"200.e13","DOI":"10.1016\/j.neurobiolaging.2016.02.024","volume":"41","author":"PG Ridge","year":"2016","unstructured":"Ridge, P. G. et al. Assessment of the genetic variance of late-onset Alzheimer\u2019s disease. Neurobiol. Aging 41, 200.e13\u2013200.e20 (2016).","journal-title":"Neurobiol. Aging"},{"key":"599_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0489-y","volume":"9","author":"CM Lewis","year":"2017","unstructured":"Lewis, C. M. & Vassos, E. Prospects for using risk scores in polygenic medicine. Genome Med. 9, 96 (2017).","journal-title":"Genome Med."},{"key":"599_CR120","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/ana.24999","volume":"82","author":"V Escott-Price","year":"2017","unstructured":"Escott-Price, V., Myers, A. J., Huentelman, M. & Hardy, J. Polygenic risk score analysis of pathologically confirmed Alzheimer disease. Ann. Neurol. 82, 311\u2013314 (2017).","journal-title":"Ann. Neurol."},{"key":"599_CR121","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jalz.2018.01.005","volume":"14","author":"S Ahmad","year":"2018","unstructured":"Ahmad, S. et al. Disentangling the biological pathways involved in early features of Alzheimer\u2019s disease in the Rotterdam Study. Alzheimers Dement. 14, 848\u2013857 (2018).","journal-title":"Alzheimers Dement."},{"key":"599_CR122","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/archneurol.2010.108","volume":"67","author":"A Biffi","year":"2010","unstructured":"Biffi, A. et al. Genetic variation and neuroimaging measures in Alzheimer disease. Arch. Neurol. 67, 677\u2013685 (2010).","journal-title":"Arch. Neurol."},{"key":"599_CR123","doi-asserted-by":"crossref","first-page":"490140","DOI":"10.4061\/2011\/490140","volume":"2011","author":"MN Braskie","year":"2011","unstructured":"Braskie, M. N., Ringman, J. M. & Thompson, P. M. Neuroimaging measures as endophenotypes in Alzheimer\u2019s disease. Int. J. Alzheimers Dis. 2011, 490140 (2011).","journal-title":"Int. J. Alzheimers Dis."},{"key":"599_CR124","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jalz.2010.03.013","volume":"6","author":"AJ Saykin","year":"2010","unstructured":"Saykin, A. J. et al. Alzheimer\u2019s Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans. Alzheimers Dement. 6, 265\u2013273 (2010).","journal-title":"Alzheimers Dement."},{"key":"599_CR125","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1212\/WNL.0000000000002922","volume":"87","author":"EC Mormino","year":"2016","unstructured":"Mormino, E. C. et al. Polygenic risk of Alzheimer disease is associated with early- and late-life processes. Neurology 87, 481\u2013488 (2016).","journal-title":"Neurology"},{"key":"599_CR126","doi-asserted-by":"publisher","first-page":"2106.e7","DOI":"10.1016\/j.neurobiolaging.2011.05.017","volume":"32","author":"J Bralten","year":"2011","unstructured":"Bralten, J. et al. CR1 genotype is associated with entorhinal cortex volume in young healthy adults. Neurobiol. Aging 32, 2106.e7\u20132106.e11 (2011).","journal-title":"Neurobiol. Aging"},{"key":"599_CR127","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jalz.2014.10.012","volume":"11","author":"TM Lancaster","year":"2015","unstructured":"Lancaster, T. M. et al. Alzheimer\u2019s disease risk variant in CLU is associated with neural inefficiency in healthy individuals. Alzheimers Dement. 11, 1144\u20131152 (2015).","journal-title":"Alzheimers Dement."},{"key":"599_CR128","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.biopsych.2016.02.033","volume":"81","author":"SF Foley","year":"2017","unstructured":"Foley, S. F. et al. Multimodal brain imaging reveals structural differences in Alzheimer\u2019s disease polygenic risk carriers: a study in healthy young adults. Biol. Psychiatry 81, 154\u2013161 (2017).","journal-title":"Biol. Psychiatry"},{"key":"599_CR129","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1176\/appi.ajp.2017.17050529","volume":"175","author":"LK Axelrud","year":"2018","unstructured":"Axelrud, L. K. et al. Polygenic risk score for Alzheimer\u2019s disease: implications for memory performance and hippocampal volumes in early life. Am. J. Psychiatry 175, 555\u2013563 (2018).","journal-title":"Am. J. Psychiatry"},{"key":"599_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36820-3","volume":"9","author":"HL Chandler","year":"2019","unstructured":"Chandler, H. L. et al. Polygenic impact of common genetic risk loci for Alzheimer\u2019s disease on cerebral blood flow in young individuals. Sci. Rep. 9, 467 (2019).","journal-title":"Sci. Rep."},{"key":"599_CR131","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2015.12.023","volume":"40","author":"MK Lupton","year":"2016","unstructured":"Lupton, M. K. et al. The effect of increased genetic risk for Alzheimer\u2019s disease on hippocampal and amygdala volume. Neurobiol. Aging 40, 68\u201377 (2016).","journal-title":"Neurobiol. Aging"},{"key":"599_CR132","doi-asserted-by":"publisher","first-page":"1765.e7","DOI":"10.1016\/j.neurobiolaging.2014.12.028","volume":"36","author":"G Chauhan","year":"2015","unstructured":"Chauhan, G. et al. Association of Alzheimer\u2019s disease GWAS loci with MRI markers of brain aging. Neurobiol. Aging 36, 1765.e7\u20131765.e16 (2015).","journal-title":"Neurobiol. Aging"},{"key":"599_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13624","volume":"8","author":"DP Hibar","year":"2017","unstructured":"Hibar, D. P. et al. Novel genetic loci associated with hippocampal volume. Nat. Commun. 8, 13624 (2017).","journal-title":"Nat. Commun."},{"key":"599_CR134","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41588-019-0511-y","volume":"51","author":"CL Satizabal","year":"2019","unstructured":"Satizabal, C.L. et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat. Genet. 51, 1624\u20131636 (2019).","journal-title":"Nat. Genet."},{"key":"599_CR135","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.neuroimage.2015.11.057","volume":"145","author":"PM Thompson","year":"2017","unstructured":"Thompson, P. M. et al. ENIGMA and the individual: predicting factors that affect the brain in 35 countries worldwide. Neuroimage 145, 389\u2013408 (2017). Pt B.","journal-title":"Neuroimage"},{"key":"599_CR136","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbi.2019.02.011","volume":"79","author":"TM Lancaster","year":"2019","unstructured":"Lancaster, T. M., Hill, M. J., Sims, R. & Williams, J. Microglia - mediated immunity partly contributes to the genetic association between Alzheimer\u2019s disease and hippocampal volume. Brain Behav. Immun. 79, 267\u2013273 (2019).","journal-title":"Brain Behav. Immun."},{"key":"599_CR137","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3233\/JAD-170045","volume":"57","author":"G Esquerda-Canals","year":"2017","unstructured":"Esquerda-Canals, G., Montoliu-Gaya, L., G\u00fcell-Bosch, J. & Villegas, S. Mouse models of Alzheimer\u2019s disease. J. Alzheimers Dis. 57, 1171\u20131183 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"599_CR138","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3233\/JAD-142802","volume":"45","author":"S Bouleau","year":"2015","unstructured":"Bouleau, S. & Tricoire, H. Drosophila models of Alzheimer\u2019s disease: advances, limits, and perspectives. J. Alzheimers Dis. 45, 1015\u20131038 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"599_CR139","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.5692\/clinicalneurol.52.1134","volume":"52","author":"T Yagi","year":"2012","unstructured":"Yagi, T. et al. [Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells]. Rinsho Shinkeigaku 52, 1134\u20131136 (2012).","journal-title":"Rinsho Shinkeigaku"},{"key":"599_CR140","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel, M. A. et al. Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature 482, 216\u2013220 (2012).","journal-title":"Nature"},{"key":"599_CR141","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.celrep.2018.07.094","volume":"24","author":"P Garcia-Reitboeck","year":"2018","unstructured":"Garcia-Reitboeck, P. et al. Human induced pluripotent stem cell-derived microglia-like cells harboring TREM2 missense mutations show specific deficits in phagocytosis. Cell Rep. 24, 2300\u20132311 (2018).","journal-title":"Cell Rep."},{"key":"599_CR142","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jalz.2018.09.006","volume":"15","author":"C Claes","year":"2019","unstructured":"Claes, C. et al. Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2. Alzheimers Dement. 15, 453\u2013464 (2019).","journal-title":"Alzheimers Dement."},{"key":"599_CR143","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. APOE \u03b54\/\u03b54 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum. Mol. Genet. 26, 2690\u20132700 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"599_CR144","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin, Y. T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141\u20131154.e7 (2018).","journal-title":"Neuron"},{"key":"599_CR145","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nn.4025","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z. et al. Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance. Nat. Neurosci. 18, 978\u2013987 (2015).","journal-title":"Nat. Neurosci."},{"key":"599_CR146","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fnins.2018.00504","volume":"12","author":"JP Robbins","year":"2018","unstructured":"Robbins, J. P. et al. Clusterin is required for \u03b2-amyloid toxicity in human iPSC-derived neurons. Front. Neurosci. 12, 504 (2018).","journal-title":"Front. Neurosci."},{"key":"599_CR147","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang, Y. A., Zhou, B., Wernig, M. & S\u00fcdhof, T. C. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion. Cell 168, 427\u2013441.e21 (2017).","journal-title":"Cell"},{"key":"599_CR148","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13195-017-0268-4","volume":"9","author":"C Arber","year":"2017","unstructured":"Arber, C., Lovejoy, C. & Wray, S. Stem cell models of Alzheimer\u2019s disease: progress and challenges. Alzheimers Res. Ther. 9, 42 (2017).","journal-title":"Alzheimers Res. Ther."},{"key":"599_CR149","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.nrl.2015.07.010","volume":"33","author":"S Rius-P\u00e9rez","year":"2018","unstructured":"Rius-P\u00e9rez, S., Tormos, A. M., P\u00e9rez, S. & Tal\u00e9ns-Visconti, R. Vascular pathology: cause or effect in Alzheimer disease? Neurologia 33, 112\u2013120 (2018).","journal-title":"Neurologia"},{"key":"599_CR150","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856\u2013860 (2015).","journal-title":"Nat. Genet."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-020-0599-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-020-0599-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-020-0599-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T09:09:11Z","timestamp":1722503351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-020-0599-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":150,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1038\/s41593-020-0599-5","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"assertion":[{"value":"18 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}